INS and chronic kidney disease: Out of the 96 CKD, HD and PD patients, 54 were on antihypertensive drugs (56.8%), 45 on lipid lowering drugs (47.3%), 32 were on beta-blockers (33.3%) and 30 on antidiabetic drugs (31.5%, amongst which 24 used insulin and 6 oral antidiabetics).